HIGHLIGHTS
- who: Romy Aarnoutse from the (UNIVERSITY) have published the article: Changes in intestinal microbiota in postmenopausal oestrogen receptor-positive breast cancer patients treated with (neo)adjuvant chemotherapy, in the Journal: (JOURNAL)
- what: The study showed that during AC-D treatment observed species richness was reduced and the abundance of specific microbial taxa changed. This is the first clinical study with longitudinal faecal sampling in breast cancer patients that explored the associations between adriamycin, cyclophosphamide and docetaxel treatment and the intestinal microbiota, as well as the impact of the intestinal microbiota on chemotherapy toxicity and tumour . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.